Extending Surgical Assistance into Microsurgery

Galen Robotics aims at filling gaps left by other surgical robotic technologies, with a focus on unserved applications in microsurgery, digital surgery, and robotic surgery.

Our Mission: expand the benefits of microsurgery by enabling precise surgical maneuvers through human-machine cooperation

The Galen Platform

How could Galen democratize microsurgery

The mission of Galen Robotics is to make surgeons lives easier through assistive technology in the operating room. To fulfill that vision, the company has developed a cooperative surgical assist device intended to fill unserved needs in the current surgical device market, including neurosurgery, otolaryngology, tissue reconstruction, intrauterine brain, and spine surgery. The Galen platform is designed to work with standard surgical instruments, improving stability and ergonomics in a variety of narrow corridor and minimally invasive procedures. Galen Robotics recently filed for clearance with the FDA for the first of many anticipated indications for the platform. Upon clearance, the company expects to be the first to launch a cooperative surgical platform “as a service.”

The company continues to work closely with Johns Hopkins University, and other university research organizations, to explore future applications based on this platform.

Our Story

How did Galen begin

Galen Robotics was founded in 2016 to commercialize the research done in the Laboratory of Computational Sensing and Robotics of Johns Hopkins University. Dr. Kevin Olds and Dr. Russell Taylor invented the Robotic ENT Microsurgical System (REMS) at JHU to expand the surgical population by improving ergonomics and tool stability during narrow corridor procedures in many surgical settings.

22 September 2023
Galen Robotics, Inc. Launches Bridge Funding Round Following FDA Approval
Enhanced Funding Set to Bolster Materials Acquisitions And Manufacturing Capacity BALTIMORE, MD – September 22, 2023 – Galen Robotics, Inc., a pioneering developer of a new breed of robotically assisted surgical systems, today announced the opening of a bridge round into its series B financing. This unique financial opportunity comes at an exciting juncture for...
23 August 2023
Galen CEO Bruce Lichorowic Weighs In on the Future of Surgical Robotics at LSI ’23 Panel
At the LSI (Life Science Intelligence) USA ‘23 Emerging Medtech Summit in Dana Point, CA, Galen CEO Bruce Lichorowic took the stage as part of a panel discussion on the evolving nature of surgical robotics and what the future might look like from the perspective of innovative new medical technology companies. The panel – Beyond...
10 August 2023
Galen Named ‘Best of Baltimore 2023’ in Medical Robotic Equipment Manufacturing
For the second consecutive year, Galen Robotics has been presented with the ‘Best of Baltimore’ award in the Medical Robotic Equipment Manufacturer category. Presented through the Baltimore Award Program, ‘Best of Baltimore’ is an annual honor recognizing the accomplishments of local enterprises within the greater Baltimore metro area and supporting the benefits of small businesses...
09 August 2023
Interconnecting QMS and Product Risk Management in MedTech: Enhancing Safety and Reliability
A Quality Management System (QMS) and the overall product risk management process in the MedTech sector are closely interconnected. The QMS provides the framework and systematic approach for managing product quality, while product risk management focuses on identifying, assessing, and mitigating risks associated with the MedTech product throughout its lifecycle. The relationship between a QMS...
12 July 2023
Galen Robotics CEO Takes Top Honors at AHNS 2023 Shark Tank
The American Head and Neck Society (AHNS) hosted its 2023 International Meeting, from July 8-12, 2023, in Montreal, Canada. The prestigious event is the largest international gathering of head and neck surgeons in the world, and only occurs once every three years. The invitation-only Shark Tank competition featured three emergent companies exploring technology with the potential...